Radiolabeled Zn-DPA as a potential infection imaging agent

26Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: A zinc-dipicolylamine analog (Zn-DPA) conjugated with a fluorophore (PSVue®794) has been shown to image bacterial infections in mice. However, radiolabeled Zn-DPA has not previously been considered for nuclear imaging of infection. Methods: Both 111In-labeled DOTA-biotin and Zn-DPA-biotin were combined using streptavidin (SA) as a noncovalent linker. Mice injected intramuscularly with Streptococcus pyogenes (infection model) or with lipopolysaccharide (LPS) (inflammation model) were coinjected intravenously with 6 μg of DPA as PSVue794 and as 111In-DOTA-biotin/SA/biotin-Zn-DPA. Periodic fluorescent and SPECT (single photon emission computed tomography)/CT (computed tomography) images were acquired, and biodistributions were obtained at 22 h. Results: Histological examination confirmed the validity of both the infection and inflammation animal models. Both the whole-body optical and nuclear images showed obvious accumulations in the target thigh in both models at all time points. At 22 h, the average target thigh accumulation of 111In was 1.66%ID/g (S.D. 0.15) in the infection mice compared to 0.58%ID/g (S.D. 0.07) in the inflammation mice (P

Cite

CITATION STYLE

APA

Liu, X., Cheng, D., Gray, B. D., Wang, Y., Akalin, A., Rusckowski, M., … Hnatowich, D. J. (2012). Radiolabeled Zn-DPA as a potential infection imaging agent. Nuclear Medicine and Biology, 39(5), 709–714. https://doi.org/10.1016/j.nucmedbio.2011.12.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free